The scope of medical intellectual property rights includes

According to the scope of intellectual property, medical intellectual property can be divided into inventions, trademarks, copyrights, trade secrets and marks of origin.

I. Pharmaceutical intellectual property rights

1. Pharmaceutical intellectual property refers to the property rights of all inventions and intellectual labor related to the pharmaceutical industry. Including five categories: patents and technical secrets; Trademarks and trade secrets; Which relates to computer software of pharmaceutical enterprises.

2. Copyright of relevant edited works created or provided with funds, materials and other creative conditions by medical institution personnel; Cooperation with other units involves research and development, marketing, technology transfer, investment and other technologies, product information and drug instructions that need to be kept confidential.

Second, the characteristics

1, intangible, the object of medical intellectual property is intangible knowledge with property value, which has the characteristics of high research and development cost, low reproduction cost and high potential profit.

2. Although these intangible assets are not actually possessed by enterprises, they can be based on contracts, registration, databases and other forms; Although it is intangible, its value can be calculated and it is an important wealth of enterprises.

3. exclusivity, also known as exclusivity, refers to the right of the owner of intellectual property to enjoy exclusive implementation, possession, income and disposal of his right object. If an invention is patented in China, no one else may obtain a patent right for an invention of the same subject in China.

4. Timeliness means that the effectiveness of medical intellectual property rights confirmed by law has a statutory time limit, and intellectual property rights obtained according to law are only protected within the time limit prescribed by law. Once the legal protection period is exceeded, intellectual property rights lose their legal effect, and the corresponding protected objects become the common wealth of all mankind and can be used by anyone.

5. Regionality means that the protection of pharmaceutical intellectual property rights has obvious national boundaries. Intellectual property rights protected according to the laws of a country can only take legal effect in that country and are not protected by law in other countries.